20/20 Biolabs, Inc. Q1 FY2026 Earnings Call

20/20 Biolabs, Inc. (AIDX)

Earnings Call FY2026 Q1 Call date: 2026-05-20 NoCallHeld

Quarter scorecard

Revenue

$353,375

-36.2% YoY

Diluted EPS

$-0.28

Gross margin

17.8%

-12.1 pp YoY

Net income

-$2.17M

OneTest $310,103

-34.2%

CLIAx $21,725

-14.7%

BioCheck $21,547

-62.2%